Crane et al. [53] have found that genetic or chemical inhibition of Tph1 protects or reverses the development of HFD-induced obesity and dysglycemia via activation of UCP1-mediated thermogenesis. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.